9 Hot (Or Not) IPOs Scheduled To Debut This Week

Nine companies are expected to IPO this week, including the year's largest IPO, EQT GP Holdings LP at $450 million. In addition, six of the nine companies are healthcare and genetics companies in the development stage. Last week, just over half of the 14 companies that were expected to IPO managed to price.

Analysts at Renaissance Capital outlined the prospects for this week's companies, noting that the market should expect similar results to last week's.

Here is Renaissance's take on the three largest companies expected to price:

• EQT GP Holdings LP: EQT GP Holdings is a "levered play" on the rising distributions of EQT Midstream Partners LP EQM natural gas pipeline. Since it IPO'd in 2012, EQT Midstream Partners has gained more than 250 percent. The stock has dipped 4 percent year-to-date. EQT GP Holdings is expected to raise $450 million at a price per share of $21 to $24.
• Fortress Transportation and Infrastructure Investors LLC: Expected to raise $400 million, Fortress Transportation is expected to price at $19 to $21 per share. The company "owns a portfolio of aviation, rail and marine transportation and logistics assets" and was formed by Fortress Investment Group LLC FIG.
• Galapagos: The Belgian biotech company is expected to offer shares in the U.S. for the first time. The company trades on the Amsterdam Stock Exchange, with shares rising more than 146 percent year-to-date. The company will raise $200 million, $55 million of which will come from Johnson & Johnson JNJ and AbbVie Inc ABBV.

Also scheduled to IPO this week are Fenix Parts, a recycled auto parts conglomerate, Arcadia Biosciences, a genetically modified seed company, MultiVir, a biotech company specializing in cancer treatment, Gelesis, a biotech company designing a weight-loss capsule for at-risk populations, Anterios, which is experimenting with botox formulations, and Jaguar Animal Health, which is focused on animal pharmaceuticals.